Check out the new issue of The ChEM-H Quarterly with updates on the latest developments at Sarafan ChEM-H: https://bit.ly/47go8FH
Sarafan ChEM-H | Stanford University
Research
Stanford, California 1,527 followers
Sarafan ChEM-H at Stanford University is a hub of innovation that brings the power of diversity to improve human health.
About us
Sarafan ChEM-H at Stanford University is a hub of innovation that harnesses the power of diversity – of disciplines and people – to advance human health and transform research, as well as recruit and train the next generation of scientific leaders. Its two major research initiatives, the Stanford Innovative Medicines Accelerator (IMA) and the Stanford Microbiome Therapies Initiative (MITI), aim to translate promising Stanford discoveries into new kinds of therapeutics for patients.
- Website
-
http://chemh.stanford.edu
External link for Sarafan ChEM-H | Stanford University
- Industry
- Research
- Company size
- 51-200 employees
- Headquarters
- Stanford, California
- Type
- Educational
- Founded
- 2014
- Specialties
- Chemistry, Biology, Medicine, Human Health, Higher Education, Science, Microbiomes, Medicinal Chemistry, High-throughput Screening, Experimental Human Biology, and Drug Discovery and Prototyping
Locations
-
Primary
290 Jane Stanford Way
Stanford, California 94305, US
Employees at Sarafan ChEM-H | Stanford University
-
Vi Dang
Administrative Associate 4 at Stanford University
-
Elizabeth Ponder
Executive Director / Non-profit & higher education leader / Drug discovery & innovation / Global Health / Diversity in STEM
-
Maria Fraboni
Financial Analyst - Sarafan ChEM-H at Stanford University
-
Karin Stein
Medicinal Chemist
Updates
-
The Stanford Innovative Medicines Accelerator (IMA) is seeking motivated candidates to join the team as Research Scientist, Molecular Pharmacology. The ideal candidate will use their expert knowledge of enzymology, biochemistry, and biophysical techniques to devise quantitative medium throughput assays to characterize the biochemical activities of novel small molecules. We welcome your interest! #molecularpharmacology #biochemistry #enzymology #sciencejobs #Stanford https://lnkd.in/gMHx4Eek
-
Our CBI students’ research, Q&As with faculty experts, awards and honors, and more in the latest Sarafan ChEM-H Quarterly Newsletter!
The ChEM-H Quarterly, Summer 2024
Sarafan ChEM-H | Stanford University on LinkedIn
-
Sarafan ChEM-H | Stanford University reposted this
Executive Director / Non-profit & higher education leader / Drug discovery & innovation / Global Health / Diversity in STEM
Calling all computational drug discovery experts - the Stanford Innovative Medicines Accelerator (IMA) is #hiring! Join our team of industry experts as we accelerate the translation of new discoveries at Stanford into medicines. https://lnkd.in/g_VtQqSz
Director of Computational Drug Discovery in Dean of Research, Stanford, California, United States
careersearch.stanford.edu
-
The Stanford Innovative Medicines Accelerator (IMA) is seeking a highly motivated and experienced scientist to serve as Director of Computational Drug Discovery. If you are interested in developing and implementing cutting-edge computational approaches to accelerate the identification and optimization of novel drug candidates across a range of therapeutic modalities and indications, we welcome your interest! #computationaldrugdiscovery #sciencejobs #stanford https://lnkd.in/gKURTr28
Director of Computational Drug Discovery in Dean of Research, Stanford, California, United States
careersearch.stanford.edu
-
Sarafan ChEM-H | Stanford University reposted this
"It's not hard to stay interested and curious in a field like organic chemistry, especially in the way it intersects with biology. There's so much we don't know about the natural world, including our own human bodies." 2022 chemistry laureate Carolyn Bertozzi, sees life as an unanswered puzzle. In her official #NobelPrize interview, she describes how we as humans walk around everyday in one of life's great mysteries. Watch here: https://bit.ly/3rD8N1b
-
Meet our Institute Scholars or 'scientific misfits', recruited in collaboration with partner departments at Stanford University, who are shaping the future of science and medicine: https://lnkd.in/e7re6AZk
Meet the Scientific Misfits
chemh.stanford.edu
-
New findings from Institute Scholar Jonathan Z. Long, first author Wei Wei, and team reveal that N-acetyltaurine, a byproduct of taurine and acetate, has an active role in body weight regulation, a finding that could lead to a new strategy for managing obesity: https://lnkd.in/gkHB_w62
Q&A: Unlocking the secrets of taurine in obesity control
brainresilience.stanford.edu
-
Congratulations to our Institute Scholar Monther Abu-Remaileh for receiving the 2024 ASCB Günter Blobel Early Career Award: https://bit.ly/4fqkYTP
-
Study by our founding director Chaitan Khosla, Sarafan ChEM-H CBI fellow Angele Sewa, Harrison Besser, and Irimpan Mathews reveals new insights about TG2, a key enzyme behind celiac disease, that could further be used to advance treatments against the disease: https://lnkd.in/ecFeHr7V
SLAC and Stanford researchers advance understanding of a key celiac enzyme | SLAC National Accelerator Laboratory